Skip to main content
Premium Trial:

Request an Annual Quote

Devil's Deal?

While personalized medicine may be able to tailor treatments to patients' specific maladies, Eleonore Pauwels and Jim Dratwa from the Woodrow Wilson International Center wonder whether it is a sort of Faustian bargain. Many of the people who contribute their DNA toward the development of personalized medicine may not be able to reap its benefits, they write at the Scientific American Guest Blog.

As an example, they point to something that occurred in Kannapolis, North Carolina. After the town's textile mill closed, a biotech complex replaced it. Town residents were soon offered a $10 WalMart card in exchange for their DNA, an offer that many took. But, as Pauwels and Dratwa note, many of the residents lack "the resources to pay for the expensive treatments and cutting-edge medicine that could come from their genetic material."

Going forward, Pauwels and Dratwa argue that this disparity between who contributes and who benefits should be addressed. They note, though, that it comes into conflict with the need for large amounts of data and the expense of bringing drugs to market.

"The success of personalized medicine will depend on our capacity to empower patients by lowering the economic and financial barriers to benefiting from the best course for prevention or care," they say.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.